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Recent neuroscientific research demonstrates that the human brain is becoming
altered by technological devices. Improvements in biotechnologies and computer based
technologies are now increasing the likelihood for the development of brain augmentation
devices in the next 20 years. We have developed the idea of an “Endomyccorhizae like
interface” (ELI) nanocognitive device as a new kind of future neuroprosthetic which aims
to facilitate neuronal network properties in individuals with neurodegenerative disorders.
The design of our ELI may overcome the problems of invasive neuroprosthetics,
post-operative inflammation, and infection and neuroprosthetic degradation. Themethod
in which our ELI is connected and integrated to neuronal networks is based on a
mechanism similar to endomyccorhizae which is the oldest and most widespread form
of plant symbiosis. We propose that the principle of Endomyccorhizae could be relevant
for developing a crossing point between the ELI and neuronal networks. Similar to
endomyccorhizae the ELI will be designed to form webs, each of which connects multiple
neurons together. The ELI will function to sense action potentials and deliver it to the
neurons it connects to. This is expected to compensate for neuronal loss in some
neurodegenerative disorders, such as Alzheimer’s disease and Parkinson’s disease.
Keywords: nano-neural symbiosis, endomyccorhiza, communicative coupling, post-surgical problems,
cerebrospinal fluid
INTRODUCTION
Recent neuroscientific research indicates that the human brain is becoming altered by technological
devices. Cognitive enhancement therapies are now underway for remediation of neurocognitive
and neurodegenerative deficits in individuals with schizophrenia and paraplegia/tetraplegia
(Hogarty and Greenwald, 2006; Aflalo et al., 2015; Wojtalik et al., 2016). Brain-machine interfaces
(BCI) have been successful in generating physical movement from brain signals which with training
enables navigating a computerized wheelchair (Bouton et al., 2016; Rajangam et al., 2016; Sharma
et al., 2016). This may path the way for future therapeutic BCIs enabling individuals to use their
limbs and produce speech (Shih et al., 2012). One of the latest neuroprosthetic (Ipsihand) allows
a paralyzed hand to move. The device detects electrical brain signals of the wearer’s intention
causing subsequent movement of the hand (Bundy et al., 2017). Recently, a 12-month BMI gait
neurorehabilitation programwas used on 8 spinal cord paraplegic patients with the aim of restoring
movement. The program utilized ongoing visual-tactile feedback and virtual reality in conjunction
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with a tactile exoskeleton and EEG-controlled robotic actuators
during walking (Donati et al., 2016). After the completion of the
program all 8 patients reported somatic sensory improvements
in several dermatomes, and regaining of voluntary motor
control in key muscles below the level of the spinal cord
lesion (Donati et al., 2016). The results indicated the possibility
of neurological recovery due to long term BMI usage which
fosters neuroplasticity (Donati et al., 2016). Furthermore,
genome editing shows promise in remedying genetic diseases
and neurological disorders. Recently, genome editing protein
(-27)GFP-Cre was delivered in vivo into a mouse brain via
bioreducible lipid nanoparticles for DNA recombination (Wang
et al., 2016).
Using the Nanotechnology for helping patients with
neurodegenerative disorders is a natural step forward in the
world of nanotechnology. Neurodegenerative disorders, such
as Parkinson’s disease or Alzheimer’s disease, cause significant
burden on the health care system, and affects the quality of life
significantly (Schrag et al., 2000; Hebert et al., 2003). This type
of disorders is associated with neural degeneration, causing
significant and pathological alterations of nerve conduction that
manifest as a neurological disorder. For example, In Parkinson’s
disease there is a degeneration of the medium spiny neurons
in the substantia nigra, which reduces stimulation of dopamine
neurons in the striatum which causes an imbalance between the
direct and indirect pathways that are connected to the motor
activity of the person (Calabresi et al., 2014).
From a neurosurgical viewpoint previous and current
neuroprosthetic research has essentially followed a mechanistic
approach to cortical function which is suitable for understanding
sensory and motor processes. However, such an approach is
not feasible for comprehending associative cortical functions
dealing with higher order cognition. This is because higher
order cognitive functions work on multiple intersecting and
widely dispersed neural networks. Our understanding of how
these networks function and co-operate in cortical and sub-
cortical areas is still insufficient, as are their evolutionary
substrates. Another issue confronting neurosurgeons has been
the surgical implantation of a neuroprosthetic device which is
fraught with various medical challenges. These have included
the precise surgical placement of a neuroprosthetic device in
order to optimize its functional capabilities. Previous studies
indicate that the type of neurosurgical implantation approach
can influence neurobiological performance (Nicolelis et al., 2003;
Liu et al., 2015). It has also been noted that speed of insertion
of a neuroprosthetic device may affect neurobiological response
(Biran et al., 2007). Furthermore, chronic electrode implants
undergo degradation. This degradation considerably reduces
recording activity in non-human primate models (Schwartz,
2004). Signal attenuation of chronic implanted electrodes is
primarily caused by host brain tissue response to a foreign object
which can lead to microglial activated inflammation and glial
scarring (Nicolelis et al., 2003; Polikov et al., 2005), resulting in
displacement of proximal neurons from the implanted electrode’s
surface. Another reported post-neurosurgical response to
prosthetic devices has been rupture of the blood brain barrier
resulting in infiltration of cytokines, platelets and leucocytes
(Polikov et al., 2005) into the CNS, increasing inflammatory
response and subsequent edema (Schmidt et al., 1993). We have
developed the idea of a “endomyccorhizae-like interface” (ELI)
nanocognitive device as a new kind of future neuroprosthetic
which aims to facilitate neuronal network properties in
individuals with neurodegenerative disorders. The design of our
ELI may overcome the problems of invasive neuroprosthetics,
post-operative inflammation and infection and neuroprosthetic
degradation.
The method in which our ELI is connected and integrated
to neuronal networks is based on a mechanism similar to
endomyccorhizae which is the oldest and most widespread form
of plant symbiosis (Brundrett, 2002). For over 400 million
years endomyccorhizae has formed ∼80 of terrestrial plant/fungi
interactions (Wang and Qiu, 2006). During endomyccorhizae,
bundles of finger like fungal extensions called mycelium
(hyphae), also known as shiro, penetrate the plant root where they
form arbuscules (branching structures) spores and vesicles within
the root cell structure (Figure 1). Due to its integrative method
mycelium facilitates mineral uptake of potassium, nitrogen,
zinc and copper to the plant root, protecting against infection
and conferring plant fitness (Sikes et al., 2010; Tahat et al.,
2010). Another significant feature of endomyccorhizae is how
mycelium interacts with other soil organisms in a beneficial
manner (Tahat et al., 2010). Endomyccorhizae may also lead
to anatomical changes in plant root morphology via mycelium
colonization (Tahat et al., 2010). Mycelium colonization can
increase plant growth and reduce pathogen invasion (Tahat et al.,
2010).
We propose that the principle of endomyccorhizae could be
relevant for developing a crossing point between the ELI and
neuronal networks. Similar to endomyccorhizae the ELI will be
designed to form webs, each of which connects multiple neurons
together. This is necessary because neurons are connected with
FIGURE 1 | The concept of the endomycorrhiza and its mechanism for
penetration into plant root cells of the plants’ roots, and how it can
simultaneously connect two different plants. This action is believed to transfer
biological properties between the plants, such as the immune response of one
plant to the other.
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many other neurons so that a single neuron can be involved
in several different neuronal circuits. The ELI will function to
sense action potentials and deliver it to the neurons it connects
to. This is expected to compensate for neuronal loss in some
neurodegenerative disorders, such as Alzheimer’s disease and
Parkinson’s disease.
HOW THE ELI WOULD WORK
The mechanism of the ELI is that it would seek the perikarya
of neurons which show increased electric activity to attach
to them, or to enter them. The ELI will consist of cation
chamber containing cations extracted from the surrounding
environment. The outbranching mesh fibers have a special type
of tip that is able to penetrate the cell membrane of a neuron
(Figure 2).
When the action potential reaches the tip of the device
that is inserted into the neuronal membrane, the influx of
cations can affect the charge of the inside of the fiber, making
it more positive. This change in charge can be transmitted
to the chamber, activating it to release cations to all other
connected neurons. As it is important to be optimal in the
use of the stored cations, the flow of cations should be timely
FIGURE 2 | Nanobot mesh consisting of a central chamber of cations that
allow cation to enter selectively and is able to store them for a short period of
time if needed. These cations can be released at when the signal comes from
any of the connected neurons through the fibers. The fibers are radial
extensions from the mesh that connect to other neurons and penetrates them
to open inside the cell. They are able to sense the actiton potential and send a
signal back to the champer to open the chamber gates to allow cations to
travel to each of the connected neurons. Chamber gates (not shown) are
gates connecting the chamber and the fibers that open when a signal is
received. Note: the diameter of the fibers is greatly enhanced for visual
presentation purposes.
controlled in a way that mimics normal action potential timing,
while it should be strong enough to pass the threshold of the
neuronal membrane for it to trigger an action potential and
propagate it to the end of the axon. In order to allow for the
control of the rate of cation release, the chamber gates should
be designed so as to mimic the natural slow-closing sodium
channels. The penetrability of the ELI should be very specific
to the neuronal axons, somas and/or dendrites. This may be
feasible by exploiting the biochemical properties of neuronal
membranes. Therefore, in theory, we may be able to target
specific neurons in specific brain regions. The ELI could be
engineered to have ligand-like properties that attach to specific
receptors on the axonal membranes, using them to penetrate the
membrane, thereby achieving connectivity. Consequently, the
ELI will have the potential to sense neurotransmitter potentials
in cell membranes. In that sense ELIs are functionally dependent
on the action potential passing through the axon of the cell.
ELIs functions only to propagate the action potential and send
it to the neurons it connects to, or it enhances the rate of the
action potential they receive. Thus, nomodification of the normal
functions of the neuron, it is rather a method of regaining the
function of the disrupted neural pathway (e.g., in individuals with
neurodegenerative disorders).
The device should be made specific to the cells it targets.
This can be done in two levels. The first level includes
engineering the device’s tips so that they have binding specificity,
like ligands, to specific membrane proteins that are different
according to cell type. This way the device will prefer binding
to this required type. The other level is electrophysiological:
The device should be engineered so that it sends the send
action potentials at a speed that is just slower than the normal
range of the speed of the targeted tissue. This way, if the
neurons are healthy, the device sends the signals from the pre-
device neurons to the post-device neurons in the refractory
period of the post-device neurons, which will not induce any
unwanted extra activation of the post-device neuron. If, however,
the pre-synaptic neurons are degenerated, the action potential
induced by the device will reach the next neurons in a resting
state.
Permanent presence of ELIs would require their energy supply
to derive from biological processes of surrounding tissues such
like thermal energy or fluid flow, electrolytes in neurons or glial
cells (Senthilnathan et al., 2016), or even ATP (Yadav et al., 2015).
DELIVERY OF ELI INTO BRAIN TISSUE
Currently, most nanotechnological devices are delivered to
various cells in the body via bloodstream (Felfoul et al.,
2016). Since the existence of blood-brain barrier may make
bloodstream delivery of nanoparticles to the brain impractical,
an ELI can be introduced directly into the cerebrospinal
fluid. This would be accomplished via injecting the ELI
through the roof of the orbit with a fine needle. Since the
meningeal structures line the endocranial side of the roof
of the orbit, this is an accessible route to penetrate into
the subarachnoid space with minimal damage to anatomical
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structures. Upon piercing the roof of the orbit the needle
would be inserted ∼1mm into the subarachnoid space, thus
entering the cerebrospinal fluid. The ELI should not float or
sink in the arachnoid space. Therefore, the specific gravity of
the ELI should be ∼1.036 grams per milliliter. We envisage
that a ELI would move in the CSF, possibly with the use of
a propeller. Alternately, biotechnologists could make ELI to
travel within the entire CNS in order to attach to its destined
neuronal site(s). Additionally, an outside probe could be used
in order to shut down any ELI that is not in a required
area.
IMMUNE RESPONSE
The ELI will be foreign to the body, and the immune system
is built to attack foreign agents like this. It is possible that
the immune system may form a capsule that might disrupt
the function of the ELI (Zhang et al., 2013). Although we do
not fully understand the mechanisms of immune system and
how to selectively inhibit it, researchers have used multiple
methods to “trick” the immune system into not attacking
foreign bodies. These methods have been suggested for medical
devices of various sizes. Some used cationic coating to suppress
immune response (Ma et al., 2011). They provided evidence
that poly (β-amino alcohols) have the ability to weaken the
response to foreign bodies. Other researchers suggest that
zwitterionic hydrogels, which are hydrogels whose molecules
contain two functional groups with opposite charges, can inhibit
encapsulation and immune response to the foreign body for at
least 3 months (Zhang et al., 2013). On the other hand, Veiseh
et al. (2015) showed that smaller-sized devices decrease immune
response compared to larger ones. These methods, and others,
should be further tested in the ELI specifically to determine
which to use and how effective it is prior to using the ELI in
humans.
FEASIBILITY OF ELI
More understanding of the processes underlying multiple
intersecting and widely dispersed neural networks will be vital
for engineering a ELI in order to modify neuronal network
properties in patients. Whether such a ELI is feasible is
probably best answered by the current research on hippocampal
prosthetics for memory replacement and recovery in subjects
with Alzheimer’s disease (AD) and cerebral trauma. So far
hippocampal prosthetics have been used on rodents. In one
animal study (rodents) the results indicated that a multi input
multi output (MIMO) model when applied to CA3 and CA1
hippocampal areas assisted in memory functioning (Berger et al.,
2012).
CONCLUSION
We propose that the ELI is a novel neuroprosthetic design whose
method of connectivity and integration with neuronal networks
is informed by endomyccorhizae. Interfacing to the nervous
system has been a considerable problem because of inflammation
and subsequent infection, degradation of the neuroprosthetic
and unwanted movement of the neuroprosthetic. Furthermore,
recent innovations in medical neurology, genetic editing, and
nano-neuroscience are making the construction of such an ELI
feasible to treat neurodegenerative conditions.
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